9.54% -0.145

アフターアワーズ： 1.42 0.045 +3.27%

C 4 Therapeutics Inc (CCCC)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

C 4 Therapeutics Inc (CCCC) 最新ニュース

04:03 AM

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

04:03 AM

10:39 AM

C4 Therapeutics stock hits 52-week low at $1.38 - Investing.com

10:39 AM

Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 02, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 02, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 02, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 02, 2025

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 02, 2025

Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewswire

Apr 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Apr 01, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025

Mar 31, 2025

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 31, 2025

Mar 28, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Mar 28, 2025

Mar 26, 2025

C4 Therapeutics stock plunges to 52-week low of $1.95 By Investing.com - Investing.com South Africa

Mar 26, 2025

C4 Therapeutics stock plunges to 52-week low of $1.95 - Investing.com

Mar 26, 2025

Mar 21, 2025

Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4) - Marketscreener.com

Mar 21, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

Dyne Therapeutics Reports Inducement Grants Under Nasdaq - GlobeNewswire

Mar 20, 2025

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer - Yahoo Finance

Mar 20, 2025

Mar 17, 2025

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Mar 17, 2025

Mar 15, 2025

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 15, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 15, 2025

Mar 14, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 14, 2025

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 14, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Mar 14, 2025

Mar 12, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 12, 2025

Mar 11, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 11, 2025

Mar 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 10, 2025

C4 Therapeutics: Getting Too Cheap To Ignore, But There's Still A Lot Of Risk Here - Seeking Alpha

Mar 10, 2025

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Mar 10, 2025

C4 Therapeutics stock hits 52-week low at $2.21 - Investing.com India

Mar 10, 2025

C4 Therapeutics stock hits 52-week low at $2.21 By Investing.com - Investing.com UK

Mar 10, 2025

Rhumbline Advisers Has $360,000 Stock Position in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Mar 10, 2025

Mar 07, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 07, 2025

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 07, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 07, 2025

Mar 06, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Mar 06, 2025

Y Intercept Hong Kong Ltd Invests $83,000 in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Mar 06, 2025

Mar 05, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Mar 05, 2025

Mar 04, 2025

C4 Therapeutics, Inc. (NASDAQ:CCCC) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough - Simply Wall St

Mar 04, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com

Mar 04, 2025

BMRN

$67.48

1.23%

INSM

$73.33

0.15%

RPRX

$31.79

1.63%

SMMT

$18.91

7.58%

BNTX

$92.01

1.40%

ONC

$264.32

3.81%

C 4 Therapeutics Inc (CCCC)

C 4 Therapeutics Inc (CCCC) 最新ニュース

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

C4 Therapeutics stock hits 52-week low at $1.38 - Investing.com

Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewswire

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

C4 Therapeutics stock plunges to 52-week low of $1.95 By Investing.com - Investing.com South Africa

C4 Therapeutics stock plunges to 52-week low of $1.95 - Investing.com

Summit Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4) - Marketscreener.com

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Dyne Therapeutics Reports Inducement Grants Under Nasdaq - GlobeNewswire

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer - Yahoo Finance

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

C4 Therapeutics: Getting Too Cheap To Ignore, But There's Still A Lot Of Risk Here - Seeking Alpha

Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

C4 Therapeutics stock hits 52-week low at $2.21 - Investing.com India

C4 Therapeutics stock hits 52-week low at $2.21 By Investing.com - Investing.com UK

Rhumbline Advisers Has $360,000 Stock Position in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Y Intercept Hong Kong Ltd Invests $83,000 in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

C4 Therapeutics, Inc. (NASDAQ:CCCC) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough - Simply Wall St

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com

CCCCに似た銘柄